Nonlinear models for repeated measurement data: an overview and update
M Davidian, DM Giltinan - Journal of agricultural, biological, and …, 2003 - Springer
Nonlinear mixed effects models for data in the form of continuous, repeated measurements
on each of a number of individuals, also known as hierarchical nonlinear models, are a …
on each of a number of individuals, also known as hierarchical nonlinear models, are a …
What is the best size descriptor to use for pharmacokinetic studies in the obese?
B Green, SB Duffull - British journal of clinical pharmacology, 2004 - Wiley Online Library
The prevalence of obesity in the western world is dramatically rising, with many of these
individuals requiring therapeutic intervention for a variety of disease states. Despite the …
individuals requiring therapeutic intervention for a variety of disease states. Despite the …
Basic concepts in population modeling, simulation, and model‐based drug development—part 2: introduction to pharmacokinetic modeling methods
DR Mould, RN Upton - CPT: pharmacometrics & systems …, 2013 - Wiley Online Library
Population pharmacokinetic models are used to describe the time course of drug exposure
in patients and to investigate sources of variability in patient exposure. They can be used to …
in patients and to investigate sources of variability in patient exposure. They can be used to …
The influence of method of administration and covariates on the pharmacokinetics of propofol in adult volunteers
TW Schnider, CF Minto, PL Gambus… - The Journal of the …, 1998 - pubs.asahq.org
Background Unresolved issues with propofol include whether the pharmacokinetics are
linear with dose, are influenced by method of administration (bolus vs. infusion), or are …
linear with dose, are influenced by method of administration (bolus vs. infusion), or are …
Influence of age and gender on the pharmacokinetics and pharmacodynamics of remifentanil: I. Model development
CF Minto, TW Schnider, TD Egan, E Youngs… - The Journal of the …, 1997 - pubs.asahq.org
Background Previous studies have reported conflicting results concerning the influence of
age and gender on the pharmacokinetics and pharmacodynamics of fentanyl, alfentanil, and …
age and gender on the pharmacokinetics and pharmacodynamics of fentanyl, alfentanil, and …
[图书][B] Nonlinear models for repeated measurement data
M Davidian - 2017 - taylorfrancis.com
Nonlinear measurement data arise in a wide variety of biological and biomedical
applications, such as longitudinal clinical trials, studies of drug kinetics and growth, and the …
applications, such as longitudinal clinical trials, studies of drug kinetics and growth, and the …
PsN-Toolkit—a collection of computer intensive statistical methods for non-linear mixed effect modeling using NONMEM
PsN-Toolkit is a collection of statistical tools for pharmacometric data analysis using the non-
linear mixed effect modeling software NONMEM. The toolkit is object oriented and written in …
linear mixed effect modeling software NONMEM. The toolkit is object oriented and written in …
Xpose—an S-PLUS based population pharmacokinetic/pharmacodynamic model building aid for NONMEM
EN Jonsson, MO Karlsson - Computer methods and programs in …, 1998 - Elsevier
The building of population pharmacokinetic/pharmacodynamic (PK/PD) models is a time
consuming and complicated task. This is partly due the lack of specialized tools for the …
consuming and complicated task. This is partly due the lack of specialized tools for the …
[图书][B] The art of modeling
PL Bonate - 2006 - Springer
The focus of this book is primarily on the development of pharmacokinetic and
pharmacokinetic-pharmacodynamic models. Models that are reported in the literature are …
pharmacokinetic-pharmacodynamic models. Models that are reported in the literature are …
Patient factors that increase infliximab clearance and shorten half-life in inflammatory bowel disease: a population pharmacokinetic study
I Dotan, Y Ron, H Yanai, S Becker… - Inflammatory bowel …, 2014 - academic.oup.com
Background Infliximab (IFX) is effective therapy for ulcerative colitis and Crohn's disease, but
it may be associated with side effects and loss of response. One loss of response …
it may be associated with side effects and loss of response. One loss of response …